Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000080568 | SCV000112470 | uncertain significance | not provided | 2015-05-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001257055 | SCV000560847 | benign | Duchenne muscular dystrophy | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000080568 | SCV001750669 | benign | not provided | 2021-06-23 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 31671740) |
Ambry Genetics | RCV002321577 | SCV002610770 | likely benign | Cardiovascular phenotype | 2019-03-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000080568 | SCV003799701 | benign | not provided | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000080568 | SCV003830050 | uncertain significance | not provided | 2021-12-18 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001826743 | SCV002085478 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2019-08-02 | no assertion criteria provided | clinical testing |